Crucell « Terug naar discussie overzicht

Vaccination drive to replace Indian vials

209 Posts, Pagina: « 1 2 3 4 5 6 7 8 9 10 11 | Laatste
maxen
0
quote:

patient schreef:

[quote=patient]
Antwoord van IR Crucell op mijn e-mail:
[/quote]

Met excuus voor de late plaatsing (aantal dagen weggeweest en geen mail opgehaald)
...
Lees vooral ook pagina 15 van dit draadje even door ;-)

Ook jij dank voor plaatsing!
patient
0
quote:

maxen schreef:

[quote=patient]
[quote=patient]
Antwoord van IR Crucell op mijn e-mail:
[/quote]

Met excuus voor de late plaatsing (aantal dagen weggeweest en geen mail opgehaald)
...
[/quote]
Lees vooral ook pagina 15 van dit draadje even door ;-)

Ook jij dank voor plaatsing!
Bedankt voor je reactie!
Blijkt wel weer dat je altijd scherp moet blijven!!
Ik ga maar weer eitjes zoeken, hoop volgend jaar met Pasen wat produktieve cellijnen te vinden.;Q))
de tuinman
0
Vergeef me dat het me spijt als ik naar de bekende weg vraag, maar is er al iets bekend wanneer Unicef de volgende opdrachten bekend gaat maken?
maxen
0
quote:

de tuinman schreef:

Vergeef me dat het me spijt als ik naar de bekende weg vraag, maar is er al iets bekend wanneer Unicef de volgende opdrachten bekend gaat maken?
pagina 18:
aossa - 2 apr 10, 13:52
[verwijderd]
4
Fault vaccines to be replaced
Wednesday, April 07,2010
KATHMANDU: Nepal will replace faulty vaccines made by an Indian company with vaccines manufactured by Crucell Berna, a South Korean biopharmaceutical company, by April 12. Vaccines made by Shantha Biotech have been suspended in Nepal by the World Health Organization (WHO) because of manufacturing errors in the vaccines.

According to an official of the Ministry of Health, Nepal will get as many as 131,000 vials of Quinvaxem, a pentavalent vaccines that protect infants from

five diseases--Diphtheria, Whooping Cough, Tetanus, Hepatitis B, and Haemophilus Influenza B.

“We will resume our vaccination drive after we get the vaccines,” Krishna Bahadur Chand, chief of the immunisation programme at Child Health Division under the Department of Health Services, said.

Nepal’s vaccination drive has been halted since March 24 after WHO recommended to DoHS that it should not use vaccines manufactured by Shantha Biotech following complaints from different countries about faults in the vaccines’ composition.

Chand also said that the National Committee for Immunisation Practices, a technical body that recommends the government on immunisation programmes, has already approved these new vaccines. Subsequently, the National Regulatory Authority, a government body that approves the procurement of new drugs, has also given a nod to this end.

The vaccines manufactured by Shanta Biotech were introduced in Nepal in April last year. In the first phase, the vaccines were brought in use in 25 Far- and Mid-West districts. The second phase of the vaccination drive started in December and included the other 50 districts.

“We have halted the immunisation drive that aimed at reducing infant mortality immediately after WHO made its recommendations, but we will continue as soon as the new vaccines enter the country,” said Dr. Praveen Misra, Secretary at the Ministry of Health.

www.southasianmedia.net/cnn.cfm?id=64...
de tuinman
0
Dat vind ik nu het mooie van deze forum. Wij wisten dit al.

In het eerste gedeelte van dit artikel praten ze over manufacturing errors.
Lijkt me nogal een grote blunder.
[verwijderd]
0
quote:

de tuinman schreef:

Dat vind ik nu het mooie van deze forum. Wij wisten dit al.

In het eerste gedeelte van dit artikel praten ze over manufacturing errors.
Lijkt me nogal een grote blunder.
Het gaat om de details ! (vind de verschillen :))
[verwijderd]
1
APR 10 -
A little over a week ago, the government prohibited the use of the pentavalent vaccination after harmful ‘suspended particles’ were found in the vials imported into the country by the United Nations Children Fund (UNICEF) through another UN body, the World Health Organisation (WHO). The five-in-one vaccine is given to children under a year old to protect them against five potential killers — diphtheria, tetanus, whooping cough, Hepatitis B, and Haemophilic influenza. But ‘manufacturing defects’ in the vaccine can prove fatal too. Five children lost their lives in Sri Lanka last year after being inoculated with vaccines with similar suspended particles.

Alarmingly, the defective lot of vaccines was distributed across 25 districts in the country between April-November last year and in the remaining 50 districts after November. There is no record of how many children have been inoculated with the potentially dangerous concoction. Government health experts are breathing a sign of relief as the vaccine seems to have done no significant harm — no dangerous side-effect of the vaccine has been reported in the country so far. They have also been quick to point the finger at the international agencies involved in vaccine import.

It cannot be a coincidence, in their view, that vaccines from the same faulty batch were dispatched to many African countries, thus fanning the age-old suspicion of the rich world trying to ‘experiment’ on poor people. To its credit, WHO has vowed to replace all 131,000 old vials, which emanated from an Indian manufacturer, with a new lot from a South Korean manufacturer.

The vaccine scandal comes hot on the heels of another infamous incident involving a UN agency, the World Food Programme (WFP). Last August, the Department of Food Technology and Quality Control found the foodstuff supplied by WFP in the Mid West to be ‘inedible’. As we have said in this space before, Nepali officials as well as politicians are quick to blame international organisations working in the country in order to hide their own failings. While we maintain that position, it would also be unwise (and potentially dangerous) to ignore genuine mistakes, made willingly or otherwise, of world bodies like WHO, which has, as in the latest vaccine case, undoubtedly failed to live up to its high standard of quality control.

As of this writing, WHO is reportedly looking into the incident. It is vital for its credibility that it gets to the heart of the matter, make the findings of the investigation public and punish the guilty for a grave error — one which put the lives of countless Nepali children in danger. Meanwhile, the process of replacement of the old lot, which has already been delayed by a week, needs to be expedited so that the children scheduled to take their periodic dose do not miss their vaccination deadlines.

www.ekantipur.com/the-kathmandu-post/...
[verwijderd]
2
Vaccine from SKorea
Last Updated : 2010-04-12 11:26 PM

Himalayn News Services
KATHMANDU: Ministry of Health and Population (MoHP) has received its first batch of Penta Vaccine from Crucell Berna Company today.
Krishna Bahadur Chand, chief of Immunisation Programme at Child Health Division, said that the country received 131,600 vials of Quinvaxem, a pediatric vaccine, for one month from a South Korea-based company.
The distribution of the vaccine had been temporarily halted since March 24 after Global Alliance for Vaccines and Immunization decided to replace Indian vaccines.

www.thehimalayantimes.com/fullTodays....

---------------------------------------------------

First batch: 131.600
For one month
209 Posts, Pagina: « 1 2 3 4 5 6 7 8 9 10 11 | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 874,02 0,00 0,00% 24 apr
AMX 925,76 0,00 0,00% 24 apr
ASCX 1.207,07 0,00 0,00% 24 apr
BEL 20 3.883,83 0,00 0,00% 24 apr
Germany40^ 18.086,70 -2,00 -0,01% 24 apr
US30^ 38.353,31 0,00 0,00% 24 apr
US500^ 5.072,39 0,00 0,00% 24 apr
Nasd100^ 17.524,13 0,00 0,00% 24 apr
Japan225^ 37.998,76 0,00 0,00% 24 apr
WTI 82,90 0,00 0,00% 24 apr
Brent 88,08 0,00 0,00% 24 apr
EUR/USD 1,0710 +0,0012 +0,11% 06:49
BTC/USD 64.558,77 -1.813,21 -2,73% 02:59
Gold spot 2.315,53 -0,58 -0,03% 06:49
#/^ Index indications calculated real time, zie disclaimer
HOGE RENDEMENTEN OP DE IEX-MODELPORTEFEUILLES > WORD NU ABONNEE EN PROFITEER VAN MAAR LIEFST 67% KORTING!

Stijgers & Dalers

Stijgers Laatst +/- % tijd
ABN AMRO BANK N.V. 15,905 0,000 0,00% 24 apr
ADYEN NV 1.418,400 0,000 0,00% 24 apr
Aegon 5,752 0,000 0,00% 24 apr
Dalers Laatst +/- % tijd
ABN AMRO BANK N.V. 15,905 0,000 0,00% 24 apr
ADYEN NV 1.418,400 0,000 0,00% 24 apr
Aegon 5,752 0,000 0,00% 24 apr

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront